30–50 Dose as in normal renal function10–30 Dose as in normal renal function. Start with a low dose and titrate slowly
<10           : Dose as in normal renal function. Start with a low dose and titrate slowly
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in GFR <10 mL/min
HD                     :Not dialysed. Dose as in GFR <10 mL/min
HDF/high flux   :Not dialysed. Dose as in GFR <10 mL/min
CAV/VVHD      :Unlikely to be dialysed. Dose as in GFR=10–30 mL/min
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
Analgesics: increased risk of bleeding with aspirin and NSAIDs; risk of CNS toxicity increased with tramadol
Anticoagulants: effect of coumarins possibly enhanced
Antidepressants: avoid concomitant use with MAOI, increased risk of toxicity; increased risk of CNS toxicity with moclobemide – avoid concomitant use; avoid concomitant use with St John’s wort; possibly enhanced serotonergic effects with duloxetine; can increase concentration of tricyclics; increased agitation and nausea with tryptophan
Anti-epileptics: convulsive threshold lowered
Antimalarials: avoid concomitant use with artemether/lumefantrine
Antivirals: plasma concentration possibly increased by ritonavir
Dopaminergics: use selegiline with caution; increased risk of CNS toxicity with rasagiline5HT 1 agonist: increased risk of CNS toxicity with sumatriptan; possibly increased risk of serotonergic effects with frovatriptanLinezolid: use with care, possibly increased risk of side effects
Lithium: increased risk of CNS effects
Sibutramine: increased risk of CNS toxicity – avoid concomitant use